Autoimmune inflammation from the Th17 perspective

Harrington, 2006, Expanding the effector CD4 T-cell repertoire: the Th17 lineage, Curr Opin Immunol, 18, 349, 10.1016/j.coi.2006.03.017

Mosmann, 1996, The expanding universe of T-cell subsets: Th1, Th2 and more, Immunol Today, 17, 138, 10.1016/0167-5699(96)80606-2

Manoury-Schwartz, 1997, High susceptibility to collagen-induced arthritis in mice lacking IFN-γ receptors, J Immunol, 158, 5504

Vermeire, 1997, Accelerated collagen-induced arthritis in IFNγ receptor-deficient mice, J Immunol, 158, 5507

Kageyama, 1998, Reduced susceptibility to collagen-induced arthritis in mice deficient in IFN-gamma receptor, J Immunol, 161, 1542

Bettelli, 2004, Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis, J Exp Med, 200, 79, 10.1084/jem.20031819

Heremans, 1996, Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: enhancement by monoclonal antibodies against interferon-γ, Eur J Immunol, 26, 2393, 10.1002/eji.1830261019

Farber, 1996, Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE), J Immunol, 156, 5

Willenborg, 1996, IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis, J Immunol, 157, 3223

Infante-Duarte, 2000, Microbial lipopetides induce the production of IL-17 in Th cells, J Immunol, 165, 6107, 10.4049/jimmunol.165.11.6107

Langrish, 2005, IL-23 drives a pathogenic T cell population that induces autoimmune inflammation, J Exp Med, 201, 233, 10.1084/jem.20041257

Cua, 2003, Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain, Nature, 421, 744, 10.1038/nature01355

Murphy, 2003, Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation, J Exp Med, 198, 1951, 10.1084/jem.20030896

Lubberts, 2005, The role of T cell interleukin-17 in conducting destructive arthritis: lessons from animal models, Arthritis Res Ther, 7, 29, 10.1186/ar1478

Harrington, 2005, Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages, Nat Immunol, 6, 1123, 10.1038/ni1254

Park, 2005, A distinct lineage of CD4 T cells regulate tissue inflammation by producing interleukin 17, Nat Immunol, 6, 1133, 10.1038/ni1261

Mangan, 2006, Transforming growth factor-β induces development of the TH17 lineage, Nature, 441, 231, 10.1038/nature04754

Veldhoen, 2006, TGFβ in the context of an inflammatory cytokine mieliu supports de novo differentiation of IL-17 producing T cells, Immunity, 24, 179, 10.1016/j.immuni.2006.01.001

Chen, 2003, Conversion of peripheral CD4+CD25− naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3, J Exp Med, 198, 1875, 10.1084/jem.20030152

Betteli, 2006, Reciprocal developmental pathways for the generation of pathogenic effects TH17 regulatory T cells, Nature, 441, 235, 10.1038/nature04753

Sutton, 2006, A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis, J Exp Med, 203, 1685, 10.1084/jem.20060285

Batten, 2006, Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells, Nat Rev Immunol, 7, 929, 10.1038/ni1375

Stumhofer, 2006, Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system, Nat Immunol, 7, 937, 10.1038/ni1376

Ivanov, 2006, The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells, Cell, 126, 1121, 10.1016/j.cell.2006.07.035

Schen, 2006, Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells, PNAS, 103, 8137, 10.1073/pnas.0600666103

Kolls, 2004, Interleukin-17 family members and inflammation, Immunity, 21, 467, 10.1016/j.immuni.2004.08.018

Beadling, 2006, Regulation of innate and adaptative immune responses by the related cytokines IL-12, IL-23, and IL-27, Arch Immunol Ther Exp, 54, 1, 10.1007/s00005-006-0002-6

Kotake, 1999, IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis, J Clin Invest, 103, 1345, 10.1172/JCI5703

Cho, 2004, Effector function of type II collagen-stimulated T cells from rheumatoid arthritis patients. Cross-talk between T cells and synovial fibroblasts, Arthritis Rheum, 50, 776, 10.1002/art.20106

Kim, 2006, Up-regulation of IL-23p19 expression in rheumatoid arthritis synovial fibroblasts by IL-17 through PI3-kinase-NF-κ-B and p38 MAPK-dependent signaling pathways, Rheumatology

Hwang, 2004, Expression of IL-17 homologs and their receptors in the synovial cells of rheumatoid arthritis patients, Mol Cell, 19, 180

Honorati, 2001, High in vivo expression of interleukin-17 receptor in synovial endothelial cells and chondrocytes from arthritis patients, Rheumatology, 40, 522, 10.1093/rheumatology/40.5.522

Aarvak, 1999, IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells, J Immunol, 162, 1246

Hwang, 2004, IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-κB- and P13-kinase/AK1-dependent pathways, Arthritis Res Ther, 6, 120, 10.1186/ar1038

Ryu, 2005, IL-17 increased the production of vascular endothelial growth factor in rheumatoid arthritis synoviocytes, Clin Rheumatol, 25, 16, 10.1007/s10067-005-1081-1

Chabaud, 2001, IL-17 derived from juxta-articular and synovium contributes to joint degradation in rheumatoid arthritis, Arthritis Res, 3, 168, 10.1186/ar294

van Bezooijen, 2002, Interleukin 17 synergises with tumor necrosis factor α to induce cartilage destruction in vitro, Ann Rheum Dis, 61, 870, 10.1136/ard.61.10.870

Raza, 2005, Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin, Arthritis Res Ther, 7, R784, 10.1186/ar1733

Kirkham, 2006, Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis. A two-year prospective study (the DAMAGE study cohort), Arthritis Rheum, 54, 1122, 10.1002/art.21749